What is the current price of Artrya Limited's stock?

Artrya Limited's stock is currently priced at A$3.07 on the Australian Securities Exchange (ASX). [View More] ( AYA.AX )

How has Artrya performed over the past year?

Artrya's stock has surged by 678% over the past year, showcasing significant performance in the market despite current stabilization at A$3.07. Stock prices can fluctuate based on market conditions, economic factors, and company-specific events.

What are some key financial ratios of Artrya Limited?

Crucial financial ratios include an EPS of -0.18 and a current ratio of 8.27, highlighting liquidity strength despite negative earnings performance. Check additional ratios via Meyka AI.

What are the future price forecasts for Artrya?

Analyst projections indicate a potential growth with prices rising to A$5.83 in the coming quarter and A$11.09 over five years, highlighting future growth prospects within the healthcare technology space.

Is Artrya Limited profitable?

Artrya is not currently profitable, with a PE ratio of -16.78, suggesting significant challenges ahead in achieving profitability. Investors should assess the impact of these metrics carefully.

AU Stocks

What’s Happening with Artrya Limited (AYA.AX)? Key Insights into the Stock’s Performance

ByHuzaifa Zahoor November 28, 2025November 28, 2025

Artrya Limited (AYA.AX) has caught the eyes of investors on the Australian Securities Exchange (ASX) with its consistently strong performance metrics. Staying steady at A$3.07, the company’s resilience in a volatile market is noteworthy. Here’s an analysis to understand Artrya’s current market position and prospects.